Condition
Low-grade Inflammation
Total Trials
7
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed5
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07194772Not ApplicableCompleted
Sucralose and Glucose Metabolism in Young Healthy Adults
NCT06355544Not Yet Recruiting
Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk
NCT01414647Not ApplicableCompleted
The Health Effect of Diet Rich in Nordic Berries
NCT02342496Not ApplicableCompletedPrimary
Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly
NCT00860197Not ApplicableCompleted
Immune Benefits of Coffee
NCT02011672Not ApplicableCompleted
Effect of Milk Ingredients on Glucose Regulation and Inflammation
NCT01390688Unknown
Brain-derived Neurotrophic Factor and Cogntive Function
Showing all 7 trials